Integrated Advisors Network’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,684
Closed -$798K 756
2025
Q4
$798K Sell
15,684
-710
-4% -$36.3K 0.04% 386
2025
Q3
$910K Buy
16,394
+4,119
+34% +$241K 0.04% 380
2025
Q2
$847K Buy
+12,275
New +$835K 0.04% 392
2025
Q1
Sell
-3,791
Closed -$326K 756
2024
Q4
$326K Sell
3,791
-8,536
-69% -$923K 0.02% 544
2024
Q3
$1.47M Sell
12,327
-11,373
-48% -$1.52M 0.07% 253
2024
Q2
$3.38M Buy
23,700
+245
+1% +$32.5K 0.17% 150
2024
Q1
$3.01M Buy
23,455
+14,977
+177% +$1.78M 0.15% 175
2023
Q4
$877K Buy
8,478
+3,063
+57% +$303K 0.05% 311
2023
Q3
$492K Buy
+5,415
New +$477K 0.03% 423
2022
Q2
Sell
-25,890
Closed -$1.44M 712
2022
Q1
$1.44M Buy
+25,890
New +$1.33M 0.08% 243

Other funds holding NVO

Integrated Advisors Network's NVO Position: Q1 2026 in Review

Integrated Advisors Network sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 15,684 shares — an estimated $798K sold.

Integrated Advisors Network first reported a position in NVO in Q1 2022 and held it in 10 quarters. The position peaked at $3.38M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Integrated Advisors Network reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Integrated Advisors Network sold 15,684 Novo Nordisk shares in Q1 2026, an estimated $798K.
  • Integrated Advisors Network first reported a position in Novo Nordisk in Q1 2022 and held it in 10 quarters.
  • Integrated Advisors Network's Novo Nordisk position peaked at $3.38M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Integrated Advisors Network's 13F filing for Q1 2026, filed 28 Apr 2026.